NASDAQ: VVOSVivos Therapeutics Inc Stock Ownership - Who owns Vivos Therapeutics?
Insider buying vs selling
Have Vivos Therapeutics Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Ronald Kirk Huntsman | Chief Executive Officer | 2022-12-23 | 20,000 | $0.50 | $10.00kBuy |
| Ronald Kirk Huntsman | Chief Executive Officer | 2022-06-01 | 4,000 | $1.83 | $7.32kBuy |
| Ronald Kirk Huntsman | Chief Executive Officer | 2022-05-31 | 8,000 | $2.03 | $16.24kBuy |
VVOS insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when VVOS insiders and whales buy or sell their stock.
VVOS Shareholders
What type of owners hold Vivos Therapeutics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Ronald Kirk Huntsman | 15.37% | 3,536,500 | $1.24M | Insider |
| Gurdev Dave Singh | 13.99% | 3,219,705 | $1.13M | Insider |
| Vanguard Group Inc | 3.18% | 731,842 | $256.14k | Institution |
| Geode Capital Management LLC | 0.88% | 201,941 | $70.68k | Institution |
| Bard Associates Inc | 0.88% | 201,704 | $70.60k | Institution |
| Credit Agricole S A | 0.26% | 59,103 | $20.69k | Institution |
| Perkins Capital Management Inc | 0.23% | 52,000 | $18.20k | Institution |
| Blackrock Inc | 0.20% | 47,107 | $16.49k | Institution |
| State Street Corp | 0.20% | 45,650 | $15.98k | Institution |
| Apexium Financial LP | 0.18% | 40,667 | $14.23k | Institution |
VVOS vs Medical Device Stocks
Vivos Therapeutics Stock Ownership FAQ
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.